Figure 2.
Figure 2. HSCs give rise to circulating hematopoietic cells and functional ECs. The liver of recipients that received transplants of 500 GFP+ KSL cells was evaluated. (A) GFP+ KSL cell–derived blood cells within a longitudinal section of a hepatic vessel (lumen (L) outlined, FITC channel only). (B) Merged image showing donor, GFP+ (green), DAPI+ (blue) nucleated blood cells coexpressing CD45 (red) and a single host-derived GFP–, CD45+ blood cell (arrow). (C) A portal vein with a donor DAPI+, GFP+, CD45– EC (arrowhead) near a donor DAPI+, GFP+, CD45+ blood cell (arrow). (D) Low-density lipoprotein (Dil-Ac-LDL, red) uptake in GFP+ ECs. Insert shows higher magnification of a single GFP+, Dil-Ac-LDL cell (arrow head). (E) A GFP+, CD45–, DAPI+ EC (arrowhead) within a portal vein from a 500 GFP+ KSL recipient 2 weeks after transplantation not injected with ac-LDL. Scale bars: A-B, 10 μm; C, 5 μm; and D-E, 20μm; original magnification, × 60 (D-E inserts).

HSCs give rise to circulating hematopoietic cells and functional ECs. The liver of recipients that received transplants of 500 GFP+ KSL cells was evaluated. (A) GFP+ KSL cell–derived blood cells within a longitudinal section of a hepatic vessel (lumen (L) outlined, FITC channel only). (B) Merged image showing donor, GFP+ (green), DAPI+ (blue) nucleated blood cells coexpressing CD45 (red) and a single host-derived GFP, CD45+ blood cell (arrow). (C) A portal vein with a donor DAPI+, GFP+, CD45 EC (arrowhead) near a donor DAPI+, GFP+, CD45+ blood cell (arrow). (D) Low-density lipoprotein (Dil-Ac-LDL, red) uptake in GFP+ ECs. Insert shows higher magnification of a single GFP+, Dil-Ac-LDL cell (arrow head). (E) A GFP+, CD45, DAPI+ EC (arrowhead) within a portal vein from a 500 GFP+ KSL recipient 2 weeks after transplantation not injected with ac-LDL. Scale bars: A-B, 10 μm; C, 5 μm; and D-E, 20μm; original magnification, × 60 (D-E inserts).

Close Modal

or Create an Account

Close Modal
Close Modal